Genetic Testing Enhances the Precision Diagnosis and Treatment of Breast Cancer
Article in International Journal of Molecular Sciences (November 2023)
The most recent citing publications are shown below. View all 6 publications that cite this research output on Dimensions.
Chinese expert consensus on multigene testing for adjuvant treatment of HR-positive, HER-2 negative early breast cancer(2023 edition)
Article in Chinese Journal of Oncology (October 2023)
RecurIndex assay as an aid for adjuvant chemotherapy decisions in HR-positive HER2-negative breast cancer patients
Article in Frontiers in Oncology (December 2022)